>

>

What is the product positioning strategy for two novel early stage IO candidates for global pharma company?

Service Areas
Therapeutic Areas

Oncology

Auto-immune

Client Type

Early Stage IO candidates

Client Problems

  • Which indications should the IO candidates be prioritized for?


     

  • How does the product positioning affect the overall IO portfolio for the company?


     

  • Go/no-go decision on mono / combotherapy

What We Did

  • Workshop with client for indication prioritization


     

  • TPP generation for each candidate across indications


     

  • Determined the impact of the candidate on the overall portfolio


     

  • Prioritized the indication selections

Our Results And Insight

  • Estimated revenue potential
     

  • Indication prioritization
     

  • Portfolio management

See other case studies

Commercial Strategy case studies >

Portfolio Management case studies >

Oncology case studies >

Auto-immune case studies >

Service Areas Details

Commercial Strategy, Portfolio Management (Disease Area Strategy)

Therapeutic Areas Details

Oncology (Solid Tumor), Auto-immune

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net